Title
Drugs in the Indian market: A review
Authors
Rajeeta Joseph1, Shruti Mulgund2,*, Sadhana K. Pawar2, Devashri P. Newaskar3 & Manasi Yewale4
Affiliation
1Department of Pharmacology, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Pune, Maharashtra, India; 2Department of Physiology and Biochemistry, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Pune, Maharashtra, India; 3Department of Periodontology, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Pune, Maharashtra, India; *Corresponding author
Rajeeta Joseph - E-mail: rajeeta.joseph@bharatividyapeeth.edu
Shruti Mulgund - E-mail: shruti.mulgund@bharatividyapeeth.edu
Sadhana K. Pawar - E-mail: sadhana.gawade@bharatividyapeeth.edu
Devashri P. Newaskar - E-mail: devashri.newaskar@bharatividyapeeth.edu
Manasi Yewale - E-mail: manasi.yewale@bharatividyapeeth.edu
Article Type
Review
Date
Received August 1, 2026; Revised August 31, 2026; Accepted August 31, 2026, Published August 31, 2026
Abstract
India supplies affordable medicines globally, yet persistent quality and regulatory failures threaten patient safety and public trust. Major concerns include substandard medicines, irrational fixed-dose combinations, weak adverse-event reporting, fragmented oversight and import-dependent active ingredients. Therefore, it is of interest to examine the scale, causes and regulatory responses associated with these interconnected market challenges. Current measures, including product bans, price controls, QR-based traceability and the pharmacovigilance programme of India, show uneven implementation. Stronger surveillance, coordinated enforcement, domestic manufacturing and innovation are required to secure quality-driven pharmaceutical leadership.
Keywords
Indian pharmaceutical industry, substandard medicines, drug pricing, pharmacovigilance, fixed-dose combinations, regulatory challenges, drug quality
Citation
Joseph et al. Bioinformation 22(8): 5165-5169 (2026)
Edited by
Vini Mehta
ISSN
0973-2063
Publisher
License
This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.
